NCT00174746View on ClinicalTrials.gov

Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

1,145

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Asthma

Interventions

DRUG

AVE2635A

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY